Company

Cadenza Bio

Biotechnology Research This Condition and Deliver Lasting Relief. Through Collaboration 5 employees

Employees: 5
Contacts: 1
Emails: 1

www.cadenza.bio LinkedIn Crunchbase

Cadenza Bio Overview

Headquarters: This Condition and Deliver Lasting Relief. Through Collaboration
Website: www.cadenza.bio
Industry: Biotechnology Research
Employees: 5
Founded: 2022
Funding: 2.4M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About Cadenza Bio

Cadenza Bio, Inc. was founded in 2022 to accelerate and support the development of a series of novel, non-steroidal, highly selective compounds targeting Estrogen Receptor β (ERβ). Our patented and patent-pending compounds have shown therapeutic efficacy in preclinical animal models of Multiple Sclerosis and Endometriosis. Our goal goes beyond incremental improvements. We are dedicated to breaking the cycle of disease and, in doing so, transforming lives. We aim not only to alleviate symptoms but to halt progression, promote repair, and restore quality of life to enable total activity, empowering patients to regain control over their health.

Cadenza Bio Contact Details

People in AeroLeads: 3
With contact data: 1
Email contacts: 1; 33.3% coverage

Cadenza Bio Org Chart

Sample employees and titles

Name	Title	Location	Contact
Tom Denison	CEO @ Smarthealth Catalyzer, Inc.		View
Carol Curtis, Ph.d.	Entreprenuer - Scientist - Advisor	Oklahoma City, Oklahoma, United States	Email
Nicole Wade	UX Designer - Executive Assistant	Austin, Texas, United States	View